Maternal-Fetal Medicine Specialist Geeta Swamy, MD, and colleagues have published "Compassionate Use of Remdesivir in Pregnant Women with Severe Covid-19," in Clinical Infectious Diseases. The abstract describes outcomes in the first 86 pregnant women with severe COVID-19 who were treated with Remdesivir.
"I am honored to share this work, which was a tremendous team effort. Pregnant women receiving Remdesivir for COVID-19 had high rates of recovery and a low rate of serious adverse events," noted Dr. Swamy.